Oki Mark K 4
4 · AYTU BIOPHARMA, INC · Filed Aug 15, 2023
Insider Transaction Report
Form 4
Oki Mark K
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2023-08-11+13,000→ 13,000 totalExercise: $1.73Exp: 2033-08-12→ Common Shares (13,000 underlying)
Footnotes (1)
- [F1]The options vest as follows: 1/3 on August 11, 2024, with the remaining options vesting in 24 equal monthly installments beginning September 11, 2024.